Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial

Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial. Circulation. 1993; 88:1-291.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.